"Yesterday panic, today forgotten", summarized EHFG President Günther Leiner. "But pandemic prevention cannot be organized when we're threatened with the next catastrophe; all measures have to be established as fast as possible so the population can be optimally protected in the event of new threats of pandemic. The nothing's going to happen attitude is completely unacceptable in view of the dimension of the catastrophes which can end up in pandemics."
In a new study by the renowned research institute for epidemics and pandemics, the London School of Hygiene and Tropical Medicine, whose results will be presented in detail at the EHFG, the most significant points of weakness criticized by experts are:
- Lack of co-ordination between human medical and veterinary measures: in many national crisis plans potentially necessary veterinary measures are not even rudimentarily considered. As a result, the fight against one of the most important possibilities for the spread of pandemics is culpably neglected.
- International co-operation is often lip service: while basically all national crisis plans contain clear declarations for close international co-operation - only a few have even lined up plans for how this international co-operation will even take place. Thus, in an emergency co-operation will function only on a very limited basis.
- Unsuitable strategies for containing potential pandemics: many countries seem to assume that the dangers of pandemics only come from abroad. Sufficient strategies for the early combat of epidemics with pandemic potential which break out inside the country are lacking.
- Vaguely formulated crisis plans: critical points are left out of many crisis plans. An example of this is the provision of vaccines. All plans recognize this as one of the key issues, but there is a lack of any developed plan for how the rapid and adequate production of vaccines can be ensured in the event of a pandemic - the same is also true for the fast provision of laboratory capacities for tests and the development of new medications and vaccines.